Ruth Massey

From Wikipedia, the free encyclopedia
Ruth Catherine Massey
Alma materTrinity College Dublin
Scientific career
InstitutionsUniversity of Bath
University of Oxford
University of Bristol
University College Cork
ThesisEnvironmentally-regulated mutation and adaptive-evolution in Salmonella typhimurium (1999)

Ruth Catherine Massey is a British molecular biologist who is a professor at University College Cork. Her research considers pathogens. She was elected to the European Molecular Biology Organization in 2023.

Early life and education[edit]

Massey studied natural sciences and microbiology at Trinity College Dublin. Her doctoral research considered salmonella tryphimurium.[1] She was a postdoctoral researcher at the University of Bath.[2] She spent some time as a postdoc at the University of Oxford, where she became interested in Gram positive bacterial pathogen.[2]

Research and career[edit]

Supported by the Wellcome Trust, Massey established her lab in the zoology department at the University of Oxford.[citation needed] She moved her lab to the University of Bath in 2007, where she spent 10 years before joining the University of Bristol as a Wellcome Trust Investigator and Professor of Microbial Pathogenicity. Massey joined University College Cork as SALI Professor for Microbiome and Health Sciences in 2021.[2]

Massey's research considers how bacteria cause infectious diseases, the interconnection between bacterial virulence and antibiotic resistance, and population-level screening for the identification of bacterial phenotypes.[citation needed] She has studied the human pathogen Staphylococcus aureus, using molecular analysis to identify redundancies and connectivities. This analysis can be used to identify new and more effective antibiotics.[citation needed] She showcased functional genomics in combination with data to understand the toxicity of bacterial phenotypes, including individual MRSA isolates.[3] At the same time, her work identified that functional genomics could be used to predict patient outcomes to infection.[4] Massey's approaches have produced valuable data that is now used in laboratories worldwide.[5]

In 2023, Massey was elected to the European Molecular Biology Organization.[6]

Selected publications[edit]

  • Clarissa Pozzi; Elaine Waters; Justine K Rudkin; et al. (5 April 2012). "Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections". PLOS Pathogens. 8 (4): e1002626. doi:10.1371/JOURNAL.PPAT.1002626. ISSN 1553-7366. PMC 3320603. PMID 22496652. Wikidata Q34229656.
  • Louise M O'Brien; Evelyn J Walsh; Ruth C Massey; Sharon J Peacock; Timothy J Foster (1 November 2002). "Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization". Cellular Microbiology. 4 (11): 759–770. doi:10.1046/J.1462-5822.2002.00231.X. ISSN 1462-5814. PMID 12427098. Wikidata Q40690863.
  • G D I de Silva; M Kantzanou; A Justice; R C Massey; A R Wilkinson; N P J Day; S J Peacock (1 February 2002). "The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit". Journal of Clinical Microbiology. 40 (2): 382–388. doi:10.1128/JCM.40.02.382-388.2002. ISSN 0095-1137. PMC 153361. PMID 11825946. Wikidata Q39746593.

References[edit]